ALB and cancer: Several biomarkers have been proposed to predict the outcomes of cancer cachexia, including inflammatory markers such as C‐reactive protein (CRP), lymphocyte‐to‐CRP ratio (LCR) and the CRP‐to‐albumin ratio (CAR) [9, 10, 11].